{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:30:57Z","timestamp":1761514257587,"version":"3.37.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007033","name":"Eisai Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.braindev.2018.07.020","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T15:07:26Z","timestamp":1535382446000},"page":"897-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Rufinamide efficacy and safety in children aged 1\u20134\u202fyears with Lennox\u2013Gastaut syndrome"],"prefix":"10.1016","volume":"40","author":[{"given":"Shin Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-8847","authenticated-orcid":false,"given":"Hoon-Chul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heung Dong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2018.07.020_b0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2147\/NDT.S1668","article-title":"Treatment of Lennox-Gastaut syndrome: overview and recent findings","volume":"4","author":"van Rijckevorsel","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.braindev.2018.07.020_b0010","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2018.07.020_b0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/11530220-000000000-00000","article-title":"Medical management of Lennox-Gastaut syndrome","volume":"24","author":"Michoulas","year":"2010","journal-title":"CNS Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.braindev.2018.07.020_b0020","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1177\/08830738020170011001","article-title":"Lennox-Gastaut syndrome","volume":"17","author":"Crumrine","year":"2002","journal-title":"J Child Neurol"},{"issue":"Suppl 7","key":"10.1016\/j.braindev.2018.07.020_b0025","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1528-1157.1993.tb04593.x","article-title":"The Lennox-Gastaut syndrome","volume":"34","author":"Dulac","year":"1993","journal-title":"Epilepsia"},{"issue":"Suppl 5","key":"10.1016\/j.braindev.2018.07.020_b0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2011.03178.x","article-title":"Rational approach to treatment options for Lennox-Gastaut syndrome","volume":"52","author":"Montouris","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2018.07.020_b0040","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.12669\/pjms.296.4385","article-title":"Stevens Johnson Syndrome associated with Lamotrigine","volume":"29","author":"Parveen","year":"2013","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.braindev.2018.07.020_b0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1756285613481257","article-title":"Topiramate: effects on cognition in patients with epilepsy, migraine headache and obesity","volume":"6","author":"Sommer","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.braindev.2018.07.020_b0050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.5455\/2319-2003.ijbcp20141230","article-title":"Rufinamide: treatment of seizures associated with Lennox-Gastaut syndrome","volume":"3","author":"Allu","year":"2014","journal-title":"Int J Basic Clin Pharmacol"},{"key":"10.1016\/j.braindev.2018.07.020_b0055","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1517\/14656566.8.12.1931","article-title":"Rufinamide: a new anti-epileptic medication","volume":"8","author":"Hakimian","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.braindev.2018.07.020_b0060","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1528-1167.2009.02160.x","article-title":"Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial","volume":"50","author":"Brodie","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2018.07.020_b0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eplepsyres.2009.12.003","article-title":"A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures","volume":"88","author":"Elger","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2018.07.020_b0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1528-1167.2010.02729.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures","volume":"52","author":"Biton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2018.07.020_b0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejpn.2015.12.015","article-title":"Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study","volume":"20","author":"Arzimanoglou","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2018.07.020_b0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.seizure.2012.02.006","article-title":"Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome","volume":"21","author":"Kim","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2018.07.020_b0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.eplepsyres.2016.01.001","article-title":"The efficacy and safety of rufinamide in drug-resistant epilepsy: a meta-analysis of double-blind, randomized, placebo controlled trials","volume":"120","author":"Xu","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2018.07.020_b0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejpn.2014.05.001","article-title":"Efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies","volume":"18","author":"Grosso","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2018.07.020_b0095","doi-asserted-by":"crossref","first-page":"280e9","DOI":"10.2174\/187231211798472511","article-title":"Investigation of the metabolism of rufinamide and its interaction with valproate","volume":"5","author":"Williams","year":"2011","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.braindev.2018.07.020_b0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clinthera.2011.01.016","article-title":"Bioavailability of three rufinamide oral suspensions compared with the marketed 400-mg tablet formulation: results from a randomized-sequence, open-label, four-period, four-sequence crossover study in healthy subjects","volume":"33","author":"Critchley","year":"2011","journal-title":"Clin Ther"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038776041830384X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038776041830384X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T16:56:02Z","timestamp":1720544162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S038776041830384X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S038776041830384X"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2018.07.020","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rufinamide efficacy and safety in children aged 1\u20134\u202fyears with Lennox\u2013Gastaut syndrome","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2018.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}